Designs, develops, monitors and evaluates GAVI's programme process
The Policy & Performance Team leads the process of new programme development by ensuring the engagement of all GAVI partners and leveraging their technical expertise; evaluating trade-offs between programmes to make certain that all resources are used wisely; and working with other teams to keep the Boards and other decision making bodies fully informed. It does so via the following three defined areas of work:
 Managing DirectorPolicy & Performance's Managing Director is Nina Schwalbe. Prior to joining GAVI in 2008, Nina directed the policy department at the Global Alliance for TB Drug Development, a product development partnership focused on the development of medicines for tuberculosis. |
monitoring and evaluation of programs, policies and "GAVI impact";
leading the design, development and revision of policies;
leading the design and where appropriate, implementation of new initiatives.
Priorities
The Policy & Performance Team's current priorities include Pneumo and Rotavirus roll-out and implementation plans for new vaccines via the Accelerated Vaccine Introduction initiative (AVI); monitoring and evaluation; and market shaping.
